CytoSorbents Corporation, a pioneering New Jersey-based company renowned for its proprietary polymer adsorption technology, is thrilled to announce a successful funding round that has raised $2,000,000. This substantial investment represents not only a vote of confidence in CytoSorbents’ innovative approach to medical device research and commercialization but also a milestone that will accelerate the advancement of life-saving therapies. For years, the company has been at the forefront of improving patient outcomes in intensive care units and during cardiothoracic surgeries through its flagship product, CytoSorb®. This breakthrough device, now distributed in over 70 countries and approved with a CE Mark in the EU, effectively removes cytokines, bilirubin, and myoglobin in various critical care applications, as well as antithrombotic agents such as ticagrelor and rivaroxaban during surgical procedures. With multiple clinical trials well underway—including two pivotal randomized controlled trials in the United States aimed at FDA approval for its DrugSorb™-ATR Antithrombotic Removal System—CytoSorbents is strategically positioned to expand its therapeutic offerings. The new funds will primarily support the enhancement of these clinical trials, thereby bolstering the development pipeline and streamlining regulatory pathways. By reinforcing its research infrastructure and propelling forward its commercialization efforts, CytoSorbents aspires to bring transformative solutions to the management of life-threatening conditions, ultimately saving more lives and reinforcing its global leadership in blood purification technologies. This financial boost underscores the company’s unwavering commitment to innovation and patient care, driving forward a future where advanced medical treatments become a standard of excellence in critical care worldwide.
CytoSorbents Clinches $2 Million Series A Funding to Power Breakthroughs in Critical Care Solutions
Get the full CytoSorbents company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Kibu, Inc
Your connection to reality. Kibu ensures you always know who's on the other end of every conversation, wherever it happens. Kibu is a security protocol that enables groups to collaborate in digital spaces secured by real-world trust. Kibu’s application and API allow organizations to protect critical workflows with a vote-based approval system. By relying on real-world trust and biometrics instead of emails or passwords, Kibu is creating a digital ecosystem where humans know who and what is real: No spam, no bots.
$10.5M Seed
today
Scout AI
Scout AI is a frontier AI lab for U.S. defense. It was founded in 2024 by Colby Adcock and Collin Otis with a mission to deploy mission-ready AI agents across unmanned systems for the Department of War and its allies. Its Fury foundation model transforms uncrewed ground, air, sea, and space platforms and payloads into intelligent, collaborative teammates that multiply warfighter effectiveness. Scout AI is based in Sunnyvale, CA and is backed by leading institutional investors including Booz Allen Ventures, Align Ventures, Draper Associates, and Perot Jain.
$100.0M Series a
today
Checkstep
Checkstep is the trusted AI content moderation software that helps global platforms detect harmful content, enforce policies, and stay compliant at scale. Combine powerful automation with human expertise to deliver safe, relevant, and compliant digital experiences. Checkstep was founded in 2020 by serial entrepreneur Guillaume Bouchard, Facebook’s former AI Integrity Manager in London, who successfully exited his first business, Bloomsbury AI, to Facebook in 2018, and by Jonathan Manfield, former Software Engineering Lead at JP Morgan with an initial focus on misinformation. The company is backed by influential personalities of the tech industry from the U.S. and U.K., including many previous founders of online platforms, such as Joe White MBE, co-founder of Moonfruit.com and British Consul General in San Francisco, Jon Oringer who founded Shutterstock, a leading stock photography provider, as well as technology specialists, such as William Tunstall-Pedoe, who founded Evi, which became Amazon Alexa, and Diana Hu, who leads the AR platform at Niantic the company behind Pokemon Go.
$4.1M Unknown
today
Liquid
Liquid is a group of people who build cultural currency and business impact for our partners. We specialise in cultural strategy, creative execution and brand scaling services.
$18.0M Seed
today
Hightouch
Hightouch is an Agentic Marketing Platform powered by the industry-leading Composable CDP. With complete brand context, customer data, and performance history in one place, Hightouch gives every marketer the power to build and ship end-to-end campaigns themselves. Teams move faster, stay on brand, and get AI marketing that actually works.
$150.0M Series d
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Scout AI United States | Series a | $100.0M | today |
| 2 |  Axoft Argentina | Series a | $55.0M | today |
| 3 |  Future Fertility Canada | Series a | $4.1M | today |
| 4 |  Cruz Foam United States | Series a | $18.0M | 1d ago |
| 5 |  mbiomics GmbH Germany | Series a | $35.3M | 1d ago |